Ling Yang1, Thomas Neuberger1,2, Keefe B Manning3,4. 1. Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA. 2. Huck Institutes of Life Science, The Pennsylvania State University, University Park, PA, USA. 3. Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA. kbm10@psu.edu. 4. Department of Surgery, Penn State Hershey Medical Center, Hershey, PA, USA. kbm10@psu.edu.
Abstract
OBJECTIVES: Thrombosis is a leading cause of failure for cardiovascular devices. While computational simulations are a powerful tool to predict thrombosis and evaluate the risk for medical devices, limited experimental data are available to validate the simulations. The aim of the current study is to provide experimental data of a growing thrombus for device-induced thrombosis. MATERIALS AND METHODS: Thrombosis within a backward-facing step (BFS), or sudden expansion was investigated, using bovine and human blood circulated through the BFS model for 30 min, with a constant inflow rate of 0.76 L/min. Real-time three-dimensional flow-compensated magnetic resonance imaging (MRI), supported with Magnevist, a contrast agent improving thrombus delineation, was applied to quantify thrombus deposition and growth within the model. RESULTS: The study showed that the BFS model induced a flow recirculation region, which facilitated thrombosis. By 30 min, in comparison to bovine blood, human blood resulted in smaller thrombus formation, in terms of the length (13.3 ± 0.6 vs. 18.1 ± 1.3 mm), height (2.3 ± 0.1 vs. 2.6 ± 0.04 mm), surface area exposed to blood (0.67 ± 0.03 vs 1.05 ± 0.08 cm2), and volume (0.069 ± 0.004 vs. 0.093 ± 0.007 cm3), with p < 0.01. Normalization of the thrombus measurements, which excluded the flow recirculation effects, suggested that the thrombus sizes increased during the first 15 min and stabilized after 20 min. Blood properties, including viscosity, hematocrit, and platelet count affected thrombosis. CONCLUSION: For the first time, contrast agent-supported real-time MRI was performed to investigate thrombus deposition and growth within a sudden expansion. This study provides experimental data for device-induced thrombosis, which is valuable for validation of computational thrombosis simulations.
OBJECTIVES: Thrombosis is a leading cause of failure for cardiovascular devices. While computational simulations are a powerful tool to predict thrombosis and evaluate the risk for medical devices, limited experimental data are available to validate the simulations. The aim of the current study is to provide experimental data of a growing thrombus for device-induced thrombosis. MATERIALS AND METHODS: Thrombosis within a backward-facing step (BFS), or sudden expansion was investigated, using bovine and human blood circulated through the BFS model for 30 min, with a constant inflow rate of 0.76 L/min. Real-time three-dimensional flow-compensated magnetic resonance imaging (MRI), supported with Magnevist, a contrast agent improving thrombus delineation, was applied to quantify thrombus deposition and growth within the model. RESULTS: The study showed that the BFS model induced a flow recirculation region, which facilitated thrombosis. By 30 min, in comparison to bovine blood, human blood resulted in smaller thrombus formation, in terms of the length (13.3 ± 0.6 vs. 18.1 ± 1.3 mm), height (2.3 ± 0.1 vs. 2.6 ± 0.04 mm), surface area exposed to blood (0.67 ± 0.03 vs 1.05 ± 0.08 cm2), and volume (0.069 ± 0.004 vs. 0.093 ± 0.007 cm3), with p < 0.01. Normalization of the thrombus measurements, which excluded the flow recirculation effects, suggested that the thrombus sizes increased during the first 15 min and stabilized after 20 min. Blood properties, including viscosity, hematocrit, and platelet count affected thrombosis. CONCLUSION: For the first time, contrast agent-supported real-time MRI was performed to investigate thrombus deposition and growth within a sudden expansion. This study provides experimental data for device-induced thrombosis, which is valuable for validation of computational thrombosis simulations.
Entities:
Keywords:
Computational fluid dynamics; Magnetic resonance imaging; Thrombosis
Authors: R Simanek; R Vormittag; C Ay; G Alguel; D Dunkler; I Schwarzinger; G Steger; U Jaeger; C Zielinski; I Pabinger Journal: J Thromb Haemost Date: 2009-11-02 Impact factor: 5.824
Authors: Ronn P Walvick; Bernt T Bråtane; Nils Henninger; Kenneth M Sicard; James Bouley; Zhanyang Yu; Eng Lo; Xiaoying Wang; Marc Fisher Journal: Stroke Date: 2011-03-03 Impact factor: 7.914
Authors: Venkat Keshav Chivukula; Jennifer A Beckman; Anthony R Prisco; Todd Dardas; Shin Lin; Jason W Smith; Nahush A Mokadam; Alberto Aliseda; Claudius Mahr Journal: Circ Heart Fail Date: 2018-04 Impact factor: 8.790
Authors: Joshua O Taylor; Kory P Witmer; Thomas Neuberger; Brent A Craven; Richard S Meyer; Steven Deutsch; Keefe B Manning Journal: J Biomech Eng Date: 2014-07 Impact factor: 2.097
Authors: Nicolas Dürrleman; Michel Pellerin; Denis Bouchard; Yves Hébert; Raymond Cartier; Louis P Perrault; Arsène Basmadjian; Michel Carrier Journal: J Thorac Cardiovasc Surg Date: 2004-05 Impact factor: 5.209
Authors: B Quaknine-Orlando; C M Samama; B Riou; P Bonnin; J J Guillosson; J L Beaumont; P Coriat Journal: Anesthesiology Date: 1999-05 Impact factor: 7.892
Authors: Rodrigo Méndez Rojano; Angela Lai; Mansur Zhussupbekov; Greg W Burgreen; Keith Cook; James F Antaki Journal: PLoS Comput Biol Date: 2022-10-03 Impact factor: 4.779